Axisresearch
List of Categories
- Aerospace & Defense
- Agriculture
- Animal Nutrition & Wellness
- Automation
- Automotive
- Chemical & Materials
- Consumer Goods and Services
- Electronics
- Energy & Mining
- Financial Services & Investment Intelligence
- Food & Beverage
- Healthcare
- Heavy Industry
- Home & Property Improvement
- Information & Communications Technology
- Investment Opportunities
- Manufacturing
- NEO
- Others
- Packaging
- Retail
- Technology & Media
- Transportation & Logistics
Sorted by Name
Publishers
Countries
Whole Slide Imaging Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 114 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 114 pages
- Published: 07-06-2019
Market Overview
The key factors propelling the whole slide imaging market are increasing usage in drug discovery processes, technological advancements in whole slide imaging, and rising popularity of virtual slides, as compared to physical slides. Also, the increasing incidence of cancer is expected to drive the growth of the overall market.
With increasing research, there are many pharmaceutical and biotech companies that have made significant investments in drug discovery. As a consequence, imaging is now performed in all drug discovery processes. Therefore, imaging and image-based technologies are now commonplace across the drug discovery workflow and hold great promise for R&D, allowing researchers to understand and work with model organisms. Thus, it is expected to improve standardization, quality, and manageability of research, and help reduce costs. Thus, as research in drug discovery increases, it is expected to directly impact the growth of the whole slide imaging market.
Digital pathology (DP) is also a rapidly growing field that has generated a lot of interest among hospitals, laboratories, surgeons, research institutes, and healthcare companies, among others. The digital pathology process is expected to significantly increase, and thereby, increase productivity and efficiency, by allowing pathologists to stay in their offices rather than travel to numerous locations.
With the advancement of digital pathology and computer-assisted artificial intelligence technology, it is inevitable that digital health will come to play an important role in the strategic planning of cancer research and precision medicine delivery.
Thus, whole slide imaging devices are increasingly being used for cancer research and precision medicine, as many diseases can be defined by being examined under the microscope. Pathologists’ involvement in precision medicine and digital technology is likely to be a key driver for improving patient care. As a result, this is a great opportunity for the growth of the market.
Scope of the Report
As per the scope of the report, whole slide imaging involves physical slides, which are transformed into digital resources that can be analyzed on any computer, easily stored, and quickly shared with colleagues wherever they are. It refers to the scanning of conventional glass slides, in order to produce digital slides, and is the most recent imaging modality being employed by pathology departments, worldwide.
Key Market Trends
Immunohistochemistry Application Segment is Expected to Grow the Fastest During the Forecast Period
Immunohistochemistry (IHC) is a method for detecting antigens or haptens in the cells of a tissue section, by using the principle of antibodies binding specifically to antigens in biological tissues. It is a widely used technique in pathology to observe protein expression in tissue samples. It is also gaining importance, as many biotech companies use immunohistochemistry in early research and later stage drug development. Thus, with more advanced processes, this method helps in faster assessment of samples.
There has also been increased use of whole slide imaging to study blood coagulation disorders to hematopoietic neoplasms. Although there has been increased interest by pharmaceutical companies to use WSI products to develop biomarkers, the acceptance of digitized images in clinical validation studies by regulatory authorities still remains a challenge.
The Asia-Pacific Market Holds the Fastest Growth, and is Expected to Follow the Same Trend over the Forecast Period
The Asia-Pacific market is witnessing the highest CAGR, owing to the same factors responsible for the growth of this market, such as increasing research on drug discovery and awareness about the benefits of WSI. The market for whole slide imaging is growing every year and generating a large number of pathology specimens each year, due to the presence of a large population base. Thus, the adoption rate of whole slide imaging in the region has also increased, and is expected to rise in the same manner over the coming years.
Competitive Landscape
In the last decade, many pharmaceutical and biotech companies made significant investments in imaging in drug discovery. There has also been increased interest by pharmaceutical companies to use WSI products to develop biomarkers, companion, or complementary diagnostics. Many manufacturing companies are, thus, looking for opportunities in different market economies, such as Europe and Canada, where the policies are not as stringent and are better integrated.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Popularity of Virtual Slides as Compared to Physical Slides
4.2.2 Technological Advancements in Whole Slide Imaging
4.2.3 Increasing Research in Drug Discovery
4.3 Market Restraints
4.3.1 Stringent Regulatory Approvals
4.3.2 High Cost of Whole Slide Imaging Systems
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Technology
5.1.1 Scanners
5.1.2 IT Infrastructure
5.1.3 Viewer
5.1.4 Image Management System
5.2 By Application
5.2.1 Telepathology
5.2.2 Cytopathology
5.2.3 Immunohistochemistry
5.2.4 Hematopathology
5.3 By End User
5.3.1 Education
5.3.2 Research
5.3.3 Clinical
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Olympus Corporation
6.1.2 Philips Healthcare
6.1.3 Definiens AG
6.1.4 Leica Microsystems GmbH
6.1.5 Ventana Medical Systems Inc.
6.1.6 Nikon Corporation
6.1.7 Visiopharm
6.1.8 3Dhistech
6.1.9 Hamamatsu Photonics KK
6.1.10 Indica Labs
6.1.11 Inspirata
6.1.12 Mikroscan Technologies Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Technology
Scanners
IT Infrastructure
Viewer
Image Management System
By Application
Telepathology
Cytopathology
Immunohistochemistry
Hematopathology
By End User
Education
Research
Clinical
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Whole Exome Sequencing Market- Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 110 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 110 pages
- Published: 07-06-2019
Market Overview
The key factors propelling the global whole exome sequencing market are the increasing applications in clinical diagnosis, high demand for the diagnosis of rare diseases, increasing R&D in the field of genomics and next-generation sequencing, and increasing demand for personalized medicine.
The increase in acceptance of next-generation sequencing methods for prediction, treatment, and monitoring of diverse chronic diseases, such as cancer, is driving the overall market.
The low cost and high speed associated with whole exome sequencing technology, technological advancements in whole exome sequencing techniques, and global alliances among leading research institutes, are some of the major driving forces for the global whole exome sequencing market.
Scope of the Report
Exome sequencing is a technique for sequencing all of the exome and protein-coding genes in a genome. This technique includes selection of the subset of DNA that encodes proteins or exons, followed by sequencing of the exonic DNA using high-throughput DNA sequencing methods. Currently, it is being widely used for the identification and the determination of genetic variants causing various diseases, such as Miller syndrome and Alzheimer’s disease. It also provides a cost-effective screening approach for the diagnosis of genetic disorders, and presents itself as a less resource-intensive alternative to whole genome sequencing in several applications, including drug discovery and development processes.
Key Market Trends
Personalized Medicine Segment by Application is Expected to Grow the Fastest During the Forecast Period
Personalized medicine aims to provide tailor-made therapies to individual patients, depending on the molecular basis of disease, and it has become popular over recent years. Rising demand for personalized medicine has created tremendous opportunities in the field of genetic medicine, and in order to exploit these opportunities, novel diagnostic and therapeutic technologies must be developed, which in turn, has resulted in the rapid expansion of the global whole exome sequencing market.
North America holds the Largest Market and is Expected to Follow the Same Trend Over the Forecast Period
North America has the largest regional market, in terms of revenue. The increasing prevalence of genetic and chronic disorders, such as cancer, ageing population, increasing demand for targeted and personalized medicine, and favorable government initiatives, are the primary factors behind the growth of the whole exome sequencing market.
Asia-Pacific is expected to be the fastest-growing market for whole exome sequencing. Regular government funding and large numbers of conferences related to the whole exome sequencing technique are the major driving forces for the Asia-Pacific whole exome sequencing market.
Competitive Landscape
There are key players that have adopted strategies, such as collaborations, partnerships, agreements, and new product launches to gain a competitive advantage in the market. In addition, the high investments made by companies, both new and old, are on R&D facilities in this technology, which are also impacting the growth of the market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1. Introduction
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Applications in the Clinical Diagnosis and High Demand for the Diagnosis of Rare Diseases
4.2.2 Increasing R&D in the Field of Genomics and Next-generation Sequencing
4.2.3 Increasing Demand for Personalized Medicine
4.3 Market Restraints
4.3.1 High Complexity of Technique and Lack of Skilled Personnel
4.3.2 Legal and Ethical Issues Associated with Whole Exome Sequencing
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. Market Segmentation
5.1 By Product
5.1.1 Systems
5.1.2 Kits
5.1.2.1 Library Preparation Kits
5.1.2.2 Target Enrichment Kits
5.1.3 Services
5.1.3.1 Sequencing Services
5.1.3.2 Data Analysis (Bioinformatics) Services
5.1.3.3 Other Services
5.2 By Technology
5.2.1 Second-generation Sequencing
5.2.1.1 Sequencing, by Synthesis (SBS)
5.2.1.2 Sequencing, by Hybridization and Ligation (SBL)
5.2.2 Third-generation Sequencing
5.3 By Application
5.3.1 Diagnostics
5.3.2 Drug Discovery and Development
5.3.3 Personalized Medicine
5.3.4 Other Applications (Agriculture, Animal Research, etc.)
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6. Competitive Landscape
6.1 Company Profiles
6.1.1 Agilent Technologies Inc.
6.1.2 Ambry Genetics Corp.
6.1.3 Beijing Genomics Institute
6.1.4 Bio-Rad Laboratories Inc.
6.1.5 Eurofins Scientific Group
6.1.6 F. Hoffmann-La Roche AG
6.1.7 GENEWIZ Inc.
6.1.8 Illumina Inc.
6.1.9 Macrogen Inc.
6.1.10 Pacific Biosciences of California Inc.
7. Market Opportunities and Future Trends
Market Segmentation
- By Product
Systems
Kits
Library Preparation Kits
Target Enrichment Kits
Services
Sequencing Services
Data Analysis (Bioinformatics) Services
Other Services
By Technology
Second-generation Sequencing
Sequencing, by Synthesis (SBS)
Sequencing, by Hybridization and Ligation (SBL)
Third-generation Sequencing
By Application
Diagnostics
Drug Discovery and Development
Personalized Medicine
Other Applications (Agriculture, Animal Research, etc.)
Geography
North America
United States
Canada
Mexico - Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Wearable Medical Devices Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 118 pages | Published: 10-06-2019 |
- Healthcare
- Mordor Intelligence
- 118 pages
- Published: 10-06-2019
Market Overview
The growth of the global wearable medical devices market is due to the increasing technological advancements and innovations, as it can improve the lifestyle of patients, as well as the general population. Currently, these devices are gaining immense popularity, due to improved technologies that are being introduced every day by key market players.
Additionally, ease-of-use and interpretation of medical devices and increasing per-capita income in developing countries are the other important factors responsible for the growth of the market.
Less attractive reimbursement for wearable devices and lack of awareness among people are hindering the growth of the market. Additionally, the cost of wearable devices is one of the major challenges for the growth prospects of the market.
Scope of the Report
Wearable medical devices are capable of diagnosing or monitoring medical conditions, combined with digital health information, typically worn over the body. The demand for wearable medical devices and remote patient monitoring are continuously increasing in the global market, where technological advancements, innovations, and rising disposable income, along with healthcare expenditure and better healthcare management using medical devices are among the major drivers. Some of the significant barriers of growth in this market include the high cost of wearable devices that varies as per the application, reimbursement issues, and lack of awareness in low- and middle-income countries.
Key Market Trends
Remote patient monitoring is expected to exhibit the fastest growth rate over the forecast period
The rise in the number of people with chronic medical conditions and increase in geriatric population are the major factors driving the growth of remote patient monitoring (RPM) services all over the world. The RPM also called homecare telehealth, is a process in which patients can use a mobile medical device to perform a routine test and send this data to healthcare professionals in real time.
Implementation of RPM can improve the management of chronic diseases by measuring critical risk indicators, such as glucose, blood pressure, etc. RPM has various benefits for end users and hospitals, such as low cost of healthcare, reduction in extended hospitalization, and fewer doctor appointments, among others. This can also help to reduce the cost associated with the treatment of chronic diseases.
North America captured the largest market share and is expected to retain its dominance
North America dominated the overall wearable medical devices market, with the United States emerging as the major contributor to the market. The United States holds the largest share in the global wearable medical devices market, primarily attributed to the early adoption of wearable medical technology and high prevalence of cardiovascular and lifestyle-related diseases, along with high per capita medical expenditure. Apart from these factors, the presence of a large pool of mid- and large-sized device manufacturers also supplements the large market share. Favorable laws for setting up a business and robust intellectual property rights environment acted as catalysts for the growth for many wearable medical device startups, many of which are now global players.
Competitive Landscape
Rising number of market players is intensifying the competition. Players, such as Fitbit, Lifesense, Apple, Garmin, and Samsung, among others, are disrupting the market by launching several new products. The rate of technological advancements in this market is very high, and therefore, competitors are continuously investing heavily in R&D activities. Moreover, the competitor activity is very high across both the online and retail channels.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Introduction to Market Drivers and Restraints
4.3 Market Drivers
4.3.1 Increasing Technological Advancements and Innovations
4.3.2 Increasing Per-capita Income in Developing Countries
4.3.3 Ease-of-use and Interpretation of Medical Devices
4.4 Market Restraints
4.4.1 High Cost of Wearable Devices
4.4.2 Unfavorable Reimbursement Issues
4.4.3 Current Lack of Awareness in Some Regions
4.5 Industry Attractiveness- Porter’s Five Forces Analysis
4.5.1 Threat of New Entrants
4.5.2 Bargaining Power of Buyers/Consumers
4.5.3 Bargaining Power of Suppliers
4.5.4 Threat of Substitute Products
4.5.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Product Type
5.1.1 Wearable Vital Sign Monitor
5.1.1.1 Wearable Heart Rate Monitor
5.1.1.2 Wearable Activity Monitor
5.1.1.3 Wearable Electrocardiograph
5.1.1.4 Wearable Sleep Monitor
5.1.2 Wearable Fetal Monitor and Obstetric Device
5.1.3 Neuro-monitoring Device
5.1.3.1 Electroencephalograph
5.1.3.2 Electromyograph
5.1.3.3 Pain Management Wearable Medical Device
5.1.3.4 Glucose/Insulin Monitoring Wearable Device
5.1.3.5 Respiratory Therapy Wearable Device
5.2 Application
5.2.1 Sports and Fitness
5.2.2 Remote Patient Monitoring
5.2.3 Home Healthcare
5.3 Device Type
5.3.1 Watch
5.3.2 Wristband
5.3.3 Clothing
5.3.4 Ear Wear
5.3.5 Other Device Types
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 United Kingdom
5.4.2.2 Germany
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Garmin Ltd
6.1.2 Apple Inc.
6.1.3 Fitbit
6.1.4 Lifesense
6.1.5 LifeWatch AG
6.1.6 Philips Electronics
6.1.7 Samsung
6.1.8 Sotera Wireless
6.1.9 Xiaomi Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
Product Type
Wearable Vital Sign Monitor
Wearable Heart Rate Monitor
Wearable Activity Monitor
Wearable Electrocardiograph
Wearable Sleep Monitor
Wearable Fetal Monitor and Obstetric Device
Neuro-monitoring Device
Electroencephalograph
Electromyograph
Pain Management Wearable Medical Device
Glucose/Insulin Monitoring Wearable Device
Respiratory Therapy Wearable Device
Application
Sports and Fitness
Remote Patient Monitoring
Home Healthcare
Device Type
Watch
Wristband
Clothing
Ear Wear
Other Device Types
Geography
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Vital Sign Monitoring Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 114 pages | Published: 10-06-2019 |
- Healthcare
- Mordor Intelligence
- 114 pages
- Published: 10-06-2019
Market Overview
The global vital sign monitoring market was valued at USD 4,413.53 million in 2018, and is estimated to be valued at USD 6,385.73 million in 2024, witnessing a CAGR of 6.35%. The growth of geriatric population and the rising prevalence and incidence of chronic diseases have resulted in an increase in the applications of devices monitoring vital signs in emergency medicine and ambulatory care. This has led to an increasing demand for advanced algorithm-based and home care monitoring equipment.
According to the United Nations, the world’s population is aging; every country in the world is witnessing a rise in the number and proportion of older people in their population. According to data from World Population Prospects: The 2017 Revision, the population of people aged 60 years and above was estimated to be 962 million (13% of the total global population), globally. The global geriatric population is expected to reach 2.1 billion by 2050. Globally, the population aged 60 years and above is growing faster than any other age group. According to the United Nations, currently, Europe has the highest percentage of population aged 60 years or over (25% of the total European population). Vital signs provide a quantification of physiological functions that are used for the monitoring of acute and chronic diseases. Vital sign monitoring essentially serves as a communication tool about patient status. Among old people, there is a greater tendency of reduced homeostasis, which makes it difficult for the body to carry out optimal physiological functions. Increasing age is associated with cardiovascular diseases, like hypertension and stiffening of arteries. In such instances, cardiovascular vital sign monitoring becomes an indispensable tool for disease management. As aging populations across various regions of the world is increasing, there is an increasing demand for vital sign monitoring devices, which is fueling the market for these devices.
Scope of the Report
The global vital sign monitoring market comprises all devices and monitoring services used in hospitals, clinics, ambulatory surgical centers, and home care settings for measuring the four vital signs of the human body, i.e., body temperature, heart rate or pulse rate, respiratory rate, and blood pressure.
Key Market Trends
Hospitals and Clinics are Expected to hold the Highest Market Share among End Users
Under the end user segmentation of the market, hospitals and clinics are believed to have the largest market size and are expected to witness a CAGR of 6.68% during the forecast period.
Vital sign monitors have been common in hospitals and clinics for more than 40 years. These play an important role in indicating a patient’s clinical conditions. Monitoring blood pressure, pulse rate, and respiration rate is a crucial aspect of patient care in hospitals. Earlier, in hospitals, nursing assistants or technicians were responsible for collecting patients’ vital signs on a scheduled basis at a periodic interval of time, which used to have errors.
According to a research conducted by the medical device manufacturer, Welch Allyn, around 10,000 transcription errors occur every year when information is miscopied or entered in the wrong chart, at a typical 200-bed hospital. The vital sign monitors minimize the chances of errors, which results in safer patient care. As patients, as well as providers, are able to adopt vital sign monitors for the ease of monitoring, hospitals are generating more demand for the same. This is resulting in a higher share of hospitals in the end user segment.
North America Dominates the Market and is Expected to do Same in the Forecast Period
North America currently dominates the market for vital sign monitoring, and is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future, owing to the well-established healthcare industry and better reimbursement facilities in the region. The United States holds majority of the market in the North American region, due to the higher adoption of digital healthcare in the country and rising investments done by companies in the region.
Competitive Landscape
The vital sign monitoring market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, owing to technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new ingredients with less prices. Companies, like A&D Medical, Hill-Rom holdings Inc., Nihon Kohden Corporation, Koninklijke Philips NV, and Medtronic PLC, hold a substantial market share in the market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Scope of the Study
1.2 Study Deliverables
1.3 Study Assumptions
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Geriatric Population
4.2.2 Increasing Application in Emergency Medicine and Ambulatory Care
4.2.3 Increasing Demand for Advanced Algorithm-based Monitoring Equipment
4.2.4 Increasing Demand for Home Care Monitoring Equipment
4.3 Market Restraints
4.3.1 User Readiness and Unresponsiveness of Some Monitoring Devices
4.3.2 Competitive Pricing Pressure and Presence of Counterfeit Products
4.4 Industry Attractiveness – Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Type of Parameter
5.1.1 Body Temperature
5.1.1.1 Analog Temperature Monitoring Devices
5.1.1.2 Digital Temperature Monitoring Devices
5.1.1.3 Other Body Temperature Monitoring Devices
5.1.2 Blood Pressure
5.1.2.1 Manual BP Monitors
5.1.2.2 Digital BP Monitors
5.1.3 Pulse Rate
5.1.3.1 Fingertip Pulse Oximeters
5.1.3.2 Hand-held Pulse Oximeters
5.1.3.3 Other Pulse Rate Monitoring Devices
5.1.4 Respiratory Rate
5.1.4.1 Capnographs
5.1.4.2 Other Respiratory Rate Monitoring Devices
5.2 By End User
5.2.1 Hospitals and Clinics
5.2.2 Ambulatory Surgical Centers
5.2.3 Home Care Settings
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 A&D Medical
6.1.2 Hill-Rom holdings Inc.
6.1.3 Nihon Kohden Corporation
6.1.4 Koninklijke Philips NV
6.1.5 Medtronic PLC
6.1.6 Contec Medical Systems
6.1.7 Mindray Medical International Limited
6.1.8 GE Healthcare
6.1.9 OSI Systems Inc. (Spacelabs Healthcare)
6.1.10 Masimo
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Type of Parameter
Body Temperature
Analog Temperature Monitoring Devices
Digital Temperature Monitoring Devices
Other Body Temperature Monitoring Devices
Blood Pressure
Manual BP Monitors
Digital BP Monitors
Pulse Rate
Fingertip Pulse Oximeters
Hand-held Pulse Oximeters
Other Pulse Rate Monitoring Devices
Respiratory Rate
Capnographs
Other Respiratory Rate Monitoring Devices
By End User
Hospitals and Clinics
Ambulatory Surgical Centers
Home Care Settings
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Vaccine Adjuvants Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 115 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 115 pages
- Published: 07-06-2019
Market Overview
The propelling factors for the growth of the vaccine adjuvants market include the unmet needs for vaccines against certain diseases, expanding government recommendations for immunizations, technological innovations, and increasing use of recombinant subunit and synthetic vaccines.
Across the world, various governmental organizations are promoting and raising awareness regarding immunization against various diseases, like anthrax, BCG, hepatitis, HPV, influenza, varicella, smallpox, and other conditions. Thus, increasing risk of infectious diseases, effectiveness of vaccines, enhanced immunogenicity, and various government initiatives are likely to enhance the demand over the forecast period.
The adjuvant market is gaining a boost from the increasing use of recombinant subunit vaccines. As usage is increasing, the demand for various adjuvants is expanding. Over the coming years, more developments are expected to take place, increasing the need for adjuvants. The market is also expected to grow with a moderate rate, primarily fuelled by the increasing adoption of biologics and biosimilars and rising R&D in vaccines across the world.
Toxicity is the single-most crucial impediment while introducing most of the adjuvants for human use. Toxicity may also increase the financial burden on market players during the development and manufacturing phases. Thus, the negative impacts of toxicity of adjuvants on vaccine manufacturing cost and safety profiles of vaccines are hindering the growth of the market.
Also, there is an increasing demand for vaccine adjuvants, which is directly related to the growth of the vaccine market. Furthermore, market penetration in the case of developing countries remains low, presenting an opportunity for global vaccine adjuvant manufacturers to enter the emerging markets early and acquire sizable market shares.
Scope of the Report
As per the scope of the report, an adjuvant is a pharmacological or immunological agent that helps in synergizing and directing the adaptive immune response to a vaccine agent. Adjuvants are basically compounds that improve the body’s immunogenic reaction against antigens. Therefore, adjuvants are majorly added to vaccines to augment their capability to persuade long-term protection and safety against any kind of infections. Vaccine adjuvants are in the method of advancement, and currently, MF59 and aluminum salts are the only adjuvants that are feasible for human usage.
Key Market Trends
Carbohydrates adjuvants is the segment under type that is expected to grow the fastest during the forecast period
Carbohydrates are easily metabolized and generate very less toxic metabolites or long-lasting tissue deposits. Due to these advantageous reasons, their acceptance and adoption have increased since its introduction in the market. Carbohydrate adjuvants with other new types have an additional role of signaling the immune system. They boost the immune response and enhance immunogenicity.
There have also been several recent developments made in the treatment of hepatitis C virus using direct acting antivirals, which has helped researchers to shorten treatment durations and minimal side effects for patients infected with HCV. A large number of research potential and possibilities are expected over the forecast period, which may be useful for better treatment of infectious diseases and cancer treatment. Thus, the growth rate is expected to be high for this type of vaccine adjuvant.
Asia-Pacific holds the fastest growth and is expected to follow the same trend over the forecast period
Asia-Pacific is expected to witness a significant growth, due to the presence of a large population prone to various chronic and infectious diseases, such as HIV, influenza, hepatitis, and cancer. Therefore, the introduction of innovative vaccine adjuvants provides better solutions to patients at marginally lower costs. The market is growing at a significant rate, owing to the development of innovative and efficient products to meet the increasing demand from end users.
Competitive Landscape
The major companies have conducted product launches, approvals, acquisitions, and collaborations for the development of novel vaccine adjuvants, thereby, building a competitive landscape in the market. Major players are engaged in the discovery and development of new adjuvants to treat fatal diseases.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Expanding Government Recommendations for Immunizations
4.2.2 Technological Innovations
4.2.3 Unmet Vaccine Market Needs for Certain Diseases
4.2.4 Increasing Use of Recombinant Subunit and Synthetic Vaccines
4.3 Market Restraints
4.3.1 Side Effects of Adjuvants
4.3.2 High Toxicity Adjuvants
4.3.3 High R&D Cost of Developing a New Adjuvant
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Mineral Salt-based Adjuvant
5.1.2 Tensoactive Adjuvants
5.1.3 Adjuvant Emulsions
5.1.4 Liposome Adjuvants
5.1.5 Carbohydrate Adjuvants
5.1.6 Bacteria-derived Adjuvants
5.1.7 Organic Adjuvants
5.1.8 Virus-like Particles (VLP)
5.1.9 Other Types
5.2 By Route of Administration
5.2.1 Active Immunostimulants
5.2.2 Carriers
5.2.3 Vehicle Adjuvants
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Adjuvance
6.1.2 Adjuvatis
6.1.3 Brenntag AG
6.1.4 Chemtrade Logistics
6.1.5 GlaxoSmithKline
6.1.6 Invivogen
6.1.7 Merck KGaA
6.1.8 Novavax
6.1.9 Oz Biosciences
6.1.10 Seppic (Air Liquide)
6.1.11 Vaxliant
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Type
Mineral Salt-based Adjuvant
Tensoactive Adjuvants
Adjuvant Emulsions
Liposome Adjuvants
Carbohydrate Adjuvants
Bacteria-derived Adjuvants
Organic Adjuvants
Virus-like Particles (VLP)
Other Types
By Route of Administration
Active Immunostimulants
Carriers
Vehicle Adjuvants
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
US In-Vitro Diagnostics Market- Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 72 pages | Published: 10-06-2019 |
- Healthcare
- Mordor Intelligence
- 72 pages
- Published: 10-06-2019
Market Overview
The key factors propelling the growth of the market is the high prevalence of chronic diseases, increasing use of POC (Point-of-care) diagnostics, advanced technologies, and increasing awareness and acceptance of personalized medicine. The increasing government healthcare expenditure and consumer’s healthcare spending are also responsible for the growth of the market.
The increase in the US in vitro diagnostics market is majorly due to the high prevalence of chronic diseases, such as heart diseases, cancer, asthma, and diabetes. It is estimated that these diseases are responsible for the majority of deaths in the United States, killing more than 1.7 million US citizens annually. Thus, IVDs have proved to be beneficial in managing these chronic conditions. IVDs help in the detection of early warning signs and individual risk factors, creating new opportunities for prevention and early intervention.
There are also emerging technological innovations, such as lab-on-a-chip, wearable devices, and POC diagnostics that are increasingly becoming an important part of the healthcare landscape. These POC diagnostic products have been developed to be used on a patient’s bedside in hospitals, to get instant results without the need of sending the samples to the lab. Thus, owing to the ease of use and the ability to provide instant results, the use of POC diagnostics in the United States is increasing rapidly.
Scope of the Report
As per the scope of the report, in vitro diagnostics are the medical devices and consumables utilized to perform in vitro tests on various biological samples. They are basically used for the diagnosis of various medical conditions. These in vitro diagnostics products can be instruments, reagents, or any system used for the diagnosis of diseases.
Key Market Trends
Cancer/Oncology is the Segment by Application that is Expected to Grow the Fastest During the Forecast Period
Oncology is expected to witness the fastest CAGR, due to the rising number of cancer cases in the United States. There is also an increasing demand for self-care devices and POC diagnostics in the United States for the treatment of chronic diseases that is expected to boost the market growth in the forthcoming years.
The infectious disease segment also holds the largest market share, due to a high prevalence of pneumonia, tuberculosis, and HIV/AIDS. Thus, with the increasing cases of infectious diseases, it is expected to contribute to the growth of the US in vitro diagnostics market.
Hospitals is the Largest Segment by End User that is Expected to Grow During the Forecast Period
Hospitals hold the largest market share, in terms of revenue, owing to the large volume of diagnostic tests carried out in hospitals and the rising volumes of Class II and Class III IVD medical devices that are being readily used for diagnostic testing. The healthcare professionals present in hospitals mostly utilize in vitro diagnostics for disease detection and to get the best results for each patient.
Competitive Landscape
Companies, like GE Healthcare, Becton Dickinson, and Quidel, are adopting strategic actions, mergers and acquisitions, and continued technological advancements, in order to retain their market share in the future. The companies are focusing on increasing technological advancements in order to address the customer needs, like fully automated systems that provide fast and accurate results.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 High Prevalence of Chronic Diseases
4.2.2 Increasing Use of Point-of-care (POC) Diagnostics Spurring the IVD Market
4.2.3 Increasing Government Healthcare Expenditure and Consumer’s Healthcare Spending
4.2.4 Advanced Technologies Fueling the IVD Market
4.2.5 Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics
4.3 Market Restraints
4.3.1 Lack of Proper Reimbursement
4.3.2 Stringent Regulatory Framework
4.3.3 Need For High Complexity Testing Centers
4.4 Porters Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Technique
5.1.1 Immunochemistry
5.1.2 POC Diagnostics
5.1.3 Molecular Diagnostics
5.1.4 Hematology
5.1.5 Tissue Diagnostics
5.1.6 Microbiology
5.1.7 Glucose Monitoring
5.1.8 Other Techniques
5.2 By Product
5.2.1 Instruments
5.2.2 Reagents
5.2.3 Data Management Systems
5.3 By Usability
5.3.1 Disposable IVD
5.3.2 Reusable IVD
5.4 By Application
5.4.1 Infectious Diseases
5.4.2 Diabetes
5.4.3 Cancer/Oncology
5.4.4 Cardiology
5.4.5 Autoimmune Diseases
5.4.6 Nephrology
5.4.7 Drug Testing
5.4.8 HIV/AIDS
5.4.9 Other Applications
5.5 By End User
5.5.1 Laboratories
5.5.2 Hospitals
5.5.3 Academia
5.5.4 Other End Users
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 F. Hoffmann-La Roche Ltd
6.1.3 Becton Dickinson & Company
6.1.4 Danaher Corporation
6.1.5 bioMerieux SA
6.1.6 Bio-Rad Laboratories, Inc.
6.1.7 Thermo Fisher Scientific Inc.
6.1.8 Qiagen
6.1.9 Siemens Healthcare GmBH
6.1.10 Sysmex Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Technique
Immunochemistry
POC Diagnostics
Molecular Diagnostics
Hematology
Tissue Diagnostics
Microbiology
Glucose Monitoring
Other Techniques
By Product
Instruments
Reagents
Data Management Systems
By Usability
Disposable IVD
Reusable IVD
By Application
Infectious Diseases
Diabetes
Cancer/Oncology
Cardiology
Autoimmune Diseases
Nephrology
Drug Testing
HIV/AIDS
Other Applications
By End User
Laboratories
Hospitals
Academia
Other End Users